SMARCA4: Current status and future perspectives in non-small-cell lung cancer
Yumeng Tian, Lu Xu, Xin Li et al. · Cancer Letters · 2022
SMARCA4, also known as transcription activator, is an ATP-dependent catalytic subunit of SWI/SNF (SWItch/Sucrose NonFermentable) chromatin-remodeling complexes that participates in the regulation of chromatin structure and gene expression by supplying energy. As a tumor suppressor that has aberrant expression in ∼10% of non-small-cell lung cancers (NSCLCs), SMARCA4 possesses many biological functions, including regulating gene expression, differentiation and transcription. Furthermore, NSCLC patients with SMARCA4 alterations have a weak response to conventional chemotherapy and poor prognosis. Therefore, the mechanisms of SMARCA4 in NSCLC development urgently need to be explored to identify novel biomarkers and precise therapeutic strategies for this subtype. This review systematically describes the biological functions of SMARCA4 and its role in NSCLC development, metastasis, functional epigenetics and potential therapeutic approaches for NSCLCs with SMARCA4 alterations. Additionally, this paper explores the relationship and regulatory mechanisms shared by SMARCA4 and its mutually exclusive catalytic subunit SMARCA2. We aim to provide innovative treatment strategies and improve clinical outcomes for NSCLC patients with SMARCA4 alterations.
Cited by 120 works. doi:10.1016/j.canlet.2022.216022 Open-access PDF
Authors
References
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- Microenvironmental regulation of metastasis
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
- Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- Purification and biochemical heterogeneity of the mammalian SWI‐SNF complex.
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
- The Effect of Advances in Lung-Cancer Treatment on Population Mortality
- SWI/SNF nucleosome remodellers and cancer